Latest filing published 15 Oct 2026 for Oruka Therapeutics, Inc., €21k.
The record for Joana Goncalves is mostly about 2026: 47 of the 90 filings are dated that year, against just 6 in 2025. They split between Oruka Therapeutics, Inc. (53 filings) and Tvardi Therapeutics, Inc. (37), with the title Chief Medical Officer at both.
The record holds 60 sales and no purchase, worth EUR 4,285,195 in total. The median, EUR 33,213, is low because many of the sales are small. The three largest are dated August 17, 2026 (EUR 321,049), July 15, 2026 (EUR 288,163) and September 15, 2026 (EUR 251,161), all at Oruka. There are also 19 option exercises and 11 share grants.
Filings are published a median of 0 days after the trade, meaning the same day, across 89 dated filings. The last twelve months hold 53 filings, of which 33 are sales.
29, 27 and 27 trades by Goncalves fall within 30 days of colleagues at Oruka Therapeutics, Inc., in that order. All in the same direction. In the same order, the colleagues are Laura Lee Sandler, Arjun Agarwal and Paul T. Quinlan.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 90 declarations